HEALTHEQUITY Enhances Executive Severance & Equity Vesting
HEALTHEQUITY, INC. announced amendments to the employment agreements for its President and CEO, CFO, Founder, and other executives on May 5, 2026, enhancing their severance payments and benefits. These changes include increased severance for the CEO to 12 months base salary plus target cash bonus, with higher benefits if termination occurs within 18 months of a change in control. Other executives will receive 12 months base salary plus target cash bonus under change-in-control scenarios. Additionally, new vesting terms for equity awards granted after March 25, 2026, were approved, allowing for accelerated vesting of time-based restricted stock units and prorated vesting eligibility for performance-based units upon certain terminations.
Key Highlights
- HEALTHEQUITY amended employment agreements for CEO, CFO, Founder, and other executives on May 5, 2026.
- CEO Scott Cutler's severance now includes 12 months base salary plus target cash bonus.
- CEO's severance increases to 18 months base salary + 150% target bonus if termination follows a change in control.
- Other executives receive 12 months base salary + target cash bonus if terminated within 18 months of a change in control.
- Severance payments are contingent on executives executing a general release of claims.
- Time-based RSUs granted after March 25, 2026, will vest if scheduled within 12 months of certain terminations.
- Performance-based PSUs will be prorated and remain eligible to vest based on actual performance after certain terminations.
Price Impact
More from HQY